BRIDGEWATER, N.J., Feb. 26, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the Cowen and Company 40th Annual Health Care Conferenc

WALTHAM, Mass., Feb. 26, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced

CRANFORD, N.J., Feb. 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the Third Annual LD Micro Virtual Conference on Wednesday, March 4, 2020

NEW YORK, Feb. 26, 2020 /PRNewswire/ --

ATLANTA, Feb. 26, 2020 /PRNewswire/ -- The American Cancer Society (ACS) awards the 2020 Medal of Honor to three doctors. The Medal of Honor is the most prestigious award bestowed to distinguished individuals or foundations who have made valuable contributions in the categories of basic research, cancer control, clinical research, and philanthropy.

JOENSUU, Finland, Feb. 26, 2020 /PRNewswire/ -- Although quitting smoking during the 1st trimester of pregnancy reduces the risk of low birth weight, it isn't enough to protect the unborn child from being born shorter and with smaller brain size, a new study from the University of Eastern Finland shows. The study looked at 1.4

MORRISTOWN, N.J., Feb. 26, 2020 /PRNewswire/ -- PLT Health Solutions, Inc. announced today that it is launching a water-dispersible form of its industry-leading Slendacor® Weight Management Complex ingredient. A former Nutraingredients Ingredient of the Year Award (2017) winner, Slendacor has been featured in top-selling consumer weight management bra

MELBOURNE, Fla., Feb. 26, 2020 /PRNewswire/ -- The Preeclampsia Foundation announced that applications are now being accepted for its 2020 Vision Grant program. The Preeclampsia Foundation will award up to two medical research Vision Grants to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 USD e

NEW YORK, Feb. 26, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") announced today that it is expanding its CD33 program studying Actimab-A into a combination trial with the chemotherapy regimen 7+3 in patients with newly diagnosed acute myeloid leukemia (AML) who have intermediate or high-risk cytogenetic or molecu

CUPERTINO, Calif., Feb. 26, 2020 /PRNewswire / -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on Tuesday, March 3, 2020.